Breaking the Frustrating Cycle of Topical Steroids in Psoriasis: A Review of a Novel Vehicle for Fixed-Dose Combination Halobetasol Propionate/Tazarotene
Journal of Drugs in Dermatology · 2023
DOI: 10.36849/jdd.7399 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Drugs in Dermatology, 2023. Verfasst von Leon Kircik und 3 weiteren Autor:innen. Hauptthemen laut MEDLINE: Propionates, Psoriasis.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Kircik, L., Bhatia, N., Lain, E., & Jacobson, A. (2023). Breaking the Frustrating Cycle of Topical Steroids in Psoriasis: A Review of a Novel Vehicle for Fixed-Dose Combination Halobetasol Propionate/Tazarotene. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.7399
Vancouver
Kircik L, Bhatia N, Lain E, Jacobson A. Breaking the Frustrating Cycle of Topical Steroids in Psoriasis: A Review of a Novel Vehicle for Fixed-Dose Combination Halobetasol Propionate/Tazarotene. Journal of Drugs in Dermatology. 2023. doi:10.36849/jdd.7399
BibTeX
@article{Kircik2023,
author = {Kircik, Leon and Bhatia, Neal and Lain, Edward and Jacobson, Abby},
title = {Breaking the Frustrating Cycle of Topical Steroids in Psoriasis: A Review of a Novel Vehicle for Fixed-Dose Combination Halobetasol Propionate/Tazarotene},
journal = {Journal of Drugs in Dermatology},
year = {2023},
doi = {10.36849/jdd.7399}
}
EUVIMED